Literature DB >> 34001927

Maternal and perinatal factors are associated with risk of pediatric central nervous system tumors and poorer survival after diagnosis.

Maral Adel Fahmideh1,2,3, Erin C Peckham-Gregory4,5,6, Jeremy M Schraw4,5,6, Murali Chintagumpala4,6,7, Stephen C Mack4,6,7, Philip J Lupo8,4,5,6,7, Michael E Scheurer8,4,5,6,7.   

Abstract

Central nervous system (CNS) tumors are the most common solid tumors in children. Findings on the role of maternal and perinatal factors on the susceptibility or outcome of these tumors are inconclusive. Therefore, we investigated the association between these early-life factors, risk, and survival of pediatric CNS tumors, using data from one of the world's largest and most diverse cancer registries. Information on pediatric CNS tumor cases (n = 1950) for the period 1995-2011 was obtained from the Texas Cancer Registry. Birth certificate controls were frequency-matched on birth year at a ratio of 10:1 for the same period. Evaluated maternal and perinatal variables were obtained from birth records. Unconditional logistic regression was used to generate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for etiological factors. Additionally, Cox proportional hazards regression was employed to assess adjusted hazard ratios (HRs) and 95% CIs for survival factors. The results indicated that Hispanic and non-Hispanic black mothers were less likely to have children with CNS tumors compared to non-Hispanic white mothers (OR 0.88 [95% CI 0.78-0.98] P-value = 0.019; OR 0.79 [95% CI 0.67-0.93 P-value = 0.004], respectively). Infants born large for gestational age (OR 1.26 [95% CI 1.07-1.47] P-value = 0.004) and those delivered pre-term (OR 1.19 [95% CI 1.04-1.38] P-value = 0.013) showed an increased risk of CNS tumors. Infants born by vaginal forceps or vacuum delivery had a higher risk of CNS tumors compared to those born by spontaneous vaginal delivery (OR 1.35 [95% CI 1.12-1.62] P-value = 0.002). Additionally, offspring of Hispanic and non-Hispanic black mothers showed a higher risk of death (HR 1.45 [95% CI 1.16-1.80] P-value = 0.001; HR 1.53 [95% CI 1.12-2.09] P-value = 0.008, respectively). Infants born by cesarean had a higher risk of death compared to those delivered vaginally (HR 1.28 [95% CI 1.05-1.57] P-value = 0.016). These findings indicate the important role of maternal and perinatal characteristics in the etiology and survival of these clinically significant malignancies.

Entities:  

Year:  2021        PMID: 34001927     DOI: 10.1038/s41598-021-88385-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

Review 1.  Review of molecular classification and treatment implications of pediatric brain tumors.

Authors:  Ana S Guerreiro Stucklin; Vijay Ramaswamy; Craig Daniels; Michael D Taylor
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

2.  Unequal Cumulative Incidence and Mortality Outcome in Childhood Brain and Central Nervous System Malignancy in the USA.

Authors:  L Holmes; P Chavan; T Blake; K Dabney
Journal:  J Racial Ethn Health Disparities       Date:  2018-03-07

3.  International Classification of Childhood Cancer, third edition.

Authors:  Eva Steliarova-Foucher; Charles Stiller; Brigitte Lacour; Peter Kaatsch
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 4.  Risk factors for childhood and adult primary brain tumors.

Authors:  Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

5.  Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Peter M de Blank; Carol Kruchko; Claire M Petersen; Peter Liao; Jonathan L Finlay; Duncan S Stearns; Johannes E Wolff; Yingli Wolinsky; John J Letterio; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-01       Impact factor: 12.300

Review 6.  Childhood brain tumors: epidemiology, current management and future directions.

Authors:  Ian F Pollack; Regina I Jakacki
Journal:  Nat Rev Neurol       Date:  2011-07-26       Impact factor: 42.937

7.  Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States.

Authors:  David A Siegel; Jun Li; Helen Ding; Simple D Singh; Jessica B King; Lori A Pollack
Journal:  Pediatr Blood Cancer       Date:  2018-10-23       Impact factor: 3.167

8.  Health disparities and impact on outcomes in children with primary central nervous system solid tumors.

Authors:  Mary T Austin; Emma Hamilton; Denna Zebda; Hoang Nguyen; Jan M Eberth; Yuchia Chang; Linda S Elting; David I Sandberg
Journal:  J Neurosurg Pediatr       Date:  2016-08-19       Impact factor: 2.375

9.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

Review 10.  Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.

Authors:  Harry R Haynes; Sandra Camelo-Piragua; Kathreena M Kurian
Journal:  Front Oncol       Date:  2014-03-24       Impact factor: 6.244

View more
  3 in total

1.  Neighborhood Socioeconomic Deprivation and Mortality in Children with Central Nervous System Tumors.

Authors:  Abiodun Olufemi Oluyomi; Michael E Scheurer; Maral Adel Fahmideh; Jeremy M Schraw; Murali Chintagumpala; Philip J Lupo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-07       Impact factor: 4.254

Review 2.  Parental Age and Childhood Lymphoma and Solid Tumor Risk: A Literature Review and Meta-Analysis.

Authors:  Allison Domingues; Kristin J Moore; Jeannette Sample; Harmeet Kharoud; Erin L Marcotte; Logan G Spector
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

Review 3.  Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights.

Authors:  Qian Zhou; Yichen Xu; Yan Zhou; Jincheng Wang
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.